1. Home
  2. LEGN vs QXO Comparison

LEGN vs QXO Comparison

Compare LEGN & QXO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEGN
  • QXO
  • Stock Information
  • Founded
  • LEGN 2014
  • QXO 1988
  • Country
  • LEGN United States
  • QXO United States
  • Employees
  • LEGN N/A
  • QXO N/A
  • Industry
  • LEGN Biotechnology: Pharmaceutical Preparations
  • QXO EDP Services
  • Sector
  • LEGN Health Care
  • QXO Technology
  • Exchange
  • LEGN Nasdaq
  • QXO Nasdaq
  • Market Cap
  • LEGN 6.0B
  • QXO 6.5B
  • IPO Year
  • LEGN 2020
  • QXO N/A
  • Fundamental
  • Price
  • LEGN $32.66
  • QXO $13.97
  • Analyst Decision
  • LEGN Strong Buy
  • QXO
  • Analyst Count
  • LEGN 13
  • QXO 0
  • Target Price
  • LEGN $80.62
  • QXO N/A
  • AVG Volume (30 Days)
  • LEGN 1.3M
  • QXO 2.1M
  • Earning Date
  • LEGN 03-10-2025
  • QXO 03-13-2025
  • Dividend Yield
  • LEGN N/A
  • QXO N/A
  • EPS Growth
  • LEGN N/A
  • QXO N/A
  • EPS
  • LEGN N/A
  • QXO N/A
  • Revenue
  • LEGN $520,183,000.00
  • QXO $56,838,941.00
  • Revenue This Year
  • LEGN $120.36
  • QXO $3.75
  • Revenue Next Year
  • LEGN $67.91
  • QXO $13,174.40
  • P/E Ratio
  • LEGN N/A
  • QXO N/A
  • Revenue Growth
  • LEGN 122.96
  • QXO 8.86
  • 52 Week Low
  • LEGN $30.17
  • QXO $10.61
  • 52 Week High
  • LEGN $70.13
  • QXO $290.00
  • Technical
  • Relative Strength Index (RSI)
  • LEGN 41.28
  • QXO 35.76
  • Support Level
  • LEGN $30.17
  • QXO $13.62
  • Resistance Level
  • LEGN $37.92
  • QXO $15.83
  • Average True Range (ATR)
  • LEGN 2.07
  • QXO 0.74
  • MACD
  • LEGN 0.12
  • QXO -0.18
  • Stochastic Oscillator
  • LEGN 32.13
  • QXO 12.64

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

About QXO QXO Inc. Common Stock

QXO Inc provides technology solutions, primarily to clients in the manufacturing, distribution and service sectors. It provides consulting and professional services, specialized programming, training and technical support also offers solutions for accounting, financial reporting, enterprise resource planning, warehouse management systems, customer relationship management, business intelligence and other applications. Additionally, QXO develops and publishes its own proprietary software.

Share on Social Networks: